The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Over the past year the shares are up 131%. Our forward projection puts the odds of a 10% gain over the next month near 45%. The street (4 analysts) rates it none, with a mean price target of $100.
Innodata Inc.
INOD · Nasdaq · USD · Market cap $1.9B · 10,020 employees
Innodata Inc.
FAIL · Does not pass the screenAt the last full screen
2026-09-16
Screened 2026-09-16 · the tape above runs as of 23:00 UTC · 20 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
What this means: price 55.41 against the desk's fair-value range, base estimate 87.14, over the last year.
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against today's price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
Innodata Inc. holds its Markdown at $55.41. The statistical read favours the sellers, held for 12 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 12 days |
| Price at the screen | $55.41 |
| Valuation | 42.95 trailing · 26.54 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 2.88 |
Five Screens, Shown in Full
Does not pass. Accounts receivable
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 2.63% | Below 33% | Interest-bearing debt is just 2.6% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 76.36% | Below 49% | Money owed to the company is 76.4% of assets, above the 49% limit. | Fail |
| Revenue purity | 0.62% | Below 5% | Only 0.6% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-16 screen. The gold marker is the market price at the same screen. A 57.3% margin of safety to the base estimate.
Third-party analyst targets: 4 covering, consensus None. The average target sits +117% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-16 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsData engineering growth masks an empty opportunity
Every time a law firm or research house drowns in documents that need sorting, Innodata steps in to clean and structure the information across borders. Revenue is rising 54 percent, return on equity sits at 39 percent, and margins have reached 14 percent, yet the opportunity rating remains none despite a stated margin of safety.
The forward multiple of 30 times earnings already prices in continued expansion, and four analysts see further upside to a 120 dollar median target. Our fair value sits well below that level, so the gap offers no real entry point once the numbers are stress-tested.
High growth can fade quickly in this field when larger platforms build their own tools or clients bring work in-house. An unknown moat leaves the business exposed if either happens. Analysis, not advice.
| Forward P/E | 26.5xcheap for a company growing this fast |
| Trailing P/E | 43.0xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 1.29 |
| EPS, forward | 2.09 |
| Revenue growth | +57.8%growing very fast |
| Profit margin | 14.7%thin but positive margins |
| Return on equity | 37.8%an exceptional return on shareholder capital |
| FCF yield | 8.91% |
| Debt to equity | 2.40heavy leverage: higher risk if revenue softens |
| Current ratio | 1.73healthy short-term liquidity |
| Beta | 2.88much more volatile than the market |
| Short interest, float | 0.15% |
| 52-week range | 34.23 - 125.14 |
| Market cap | $1.9B |
| Employees | 10,020 |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeINOD trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 39.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Over the past year the shares are up 131%. Our forward projection puts the odds of a 10% gain over the next month near 45%. The street (4 analysts) rates it none, with a mean price target of $100.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Over the past year the shares are up 131%. Our forward projection puts the odds of a 10% gain over the next month near 45%. The street (4 analysts) rates it none, with a mean price target of $100.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Cerebras Systems vs. Innodata: Which AI-Driven Tech Stock Is a Better Buy in 2026? Motley Fool · 2d ago
- Innodata's Customer Diversification Effort: Is It Finally Paying Off? Zacks · 4d ago
- 3 AI Stocks Poised to Outperform Micron and Sandisk as the Next Infrastructure Bottleneck Builds Motley Fool · 6d ago
- Innodata Stock Plunges 47% in 3 Months: Is a Recovery Ahead? Zacks · 6d ago
- BigBear.ai vs. Innodata: Which Technology Stock Is a Better Buy in 2026? Motley Fool · 10d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $103.83 | -3.6% | · | $964 | -3.6% |
| 2 months | $35.58 | +181.3% | · | $2,813 | +181.3% |
| 3 months | $42.75 | +134.1% | · | $2,341 | +134.1% |
| 6 months | $54.26 | +84.5% | · | $1,845 | +84.5% |
| 1 year | $43.27 | +131.3% | · | $2,313 | +131.3% |
| 2 years | $15.78 | +534.2% | · | $6,342 | +534.2% |
| 3 years | $10.48 | +855.0% | · | $9,550 | +855.0% |
| 5 years | $7.24 | +1,282.3% | · | $13,823 | +1,282.3% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever INOD does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.